Comparison of the Effect of Ciprofloxacin and Nalidixic Acid in the Infection of Different Parts of the Urinary Tract
Abstract
Background: Urinary tract infection (UTI) is one of the most common bacterial infections. The most common cause is Escherichia coli. This research is done with the aim at compare effect of ciprofloxacin with nalidixic acid in the infection of different parts of the urinary tract. Methods: In this cross-sectional study, 130 patients with symptoms of the urinary tract infection referred to Imam Hossain Hospital of Shahrood were studied. For the all patients, urine samples were collected by standard method and urine analysis and culture was performed. Then, positive culture samples were tested by antibiogram and the resistance rate for the two antibiotics ciprofloxacin and nalidixic acid and MBC and MIC was investigated. Results: Of the 130 patients with symptoms of UTI (fever, flank pain or tenderness and dysuria, urgency or frequency (84 patients had positive urine culture. Of all patients with positive urine, 31 cases had symptoms of pyelonephritis, 25 patients had symptoms of cystitis and 28 patients had symptoms of UTI. In antibiogram for positive urine samples, 21 pieces were resistant to ciprofloxacin and 46 pieces were resistant to nalidixic acid which significantly reduced resistance to ciprofloxacin (P=0.005). There was no significant difference between the two antibiotics in place of clinical symptoms and drug resistance. So there was no significant difference between the two MIC and MBC in place of clinical symptoms and drug resistance. Conclusions: This study…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 130 participants or records.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.